Meme Insider
DefiLlama Now Tracking Bio Protocol on Ethereum and Base: A Boost for DeSci Projects
Explore DefiLlama's latest addition of Bio Protocol, a decentralized science platform revolutionizing biotech funding on Ethereum and Base, with over $20M in TVL.
Latest News on $BIO Protocol: Upbit Listing and Key DeSci Developments
Dive into the recent updates from Bio Protocol ($BIO), featuring a major listing on Upbit, strategic partnerships with Binance Labs and Pfizer Ventures, and advancements in decentralized science funding.
Bio Protocol Launchpad Overhaul and Upbit Listing: Scaling Strategy or Short-Term Pump?
Dive into Bio Protocol's strategic infrastructure upgrades timed with its Upbit exchange listing, exploring if $BIO is gearing up for sustainable growth in the DeSci space amid Korean market hype.
DeSci Rebrand to DeScAi: How AI is Dominating Crypto Mindshare Trends
Dive into the latest crypto mindshare shifts where AI surges ahead, DeSci eyes a rebrand to DeScAi driven by Bio Protocol, and what it means for sectors like memes and DeFi.
Bio Protocol Raises $6.9M: How AI BioAgents Are Set to Disrupt Biotech and DeSci
Bio Protocol just landed $6.9M in funding from heavyweights like Animoca Brands and Arthur Hayes' Maelstrom Fund. Dive into how their AI 'BioAgents' could slash drug discovery timelines and supercharge decentralized science on blockchain.
Bio Protocol's Aubrai Agent Generates $180K in Fees: Revolutionizing AI Crypto Research
Dive into Aubrai's impressive $180K fees on $20M volume, 67% win rate, and autonomous hypothesis generation—unlocking the future of AI agents in blockchain and DeSci.
Bio Protocol ($BIO) Joins BSC News: The DeSci Innovator Backed by Arthur Hayes and Binance Labs
Bio Protocol, a cutting-edge DeSci platform revolutionizing biotech funding with AI and blockchain, gets spotlighted on BSC News. Dive into its $6.9M seed round, $BIO token, and why it's a must-watch in crypto.
Bio Protocol's $6.9M Raise: Paul Kohlhaas Shares Insights on DeSci, AI Integration, and Liquid Science
Dive into Bio Protocol's recent $6.9 million funding round led by Arthur Hayes' Maelstrom Fund, and hear from CEO Paul Kohlhaas on how AI and crypto are transforming decentralized science for faster biotech breakthroughs.
Paul Kohlhaas Reveals Bio Protocol's Edge in DeSci: Tapping Desperate Scientists and Top AI Labs
In a candid clip from The Rollup, Bio Protocol CEO Paul Kohlhaas explains how desperate scientists and partnerships with AI powerhouses like Sakana AI give his DeSci project a massive competitive advantage in the blockchain world.
AI Agents vs Prediction Markets: Why Aubrai's $AUBRAI is Turning Heads in Crypto
Explore how AI agents in projects like Aubrai are outpacing prediction markets in innovation, as highlighted in S4mmyEth's viral tweet on Bio Protocol's DeSci advancements.